Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: J Neuroendocrinol. 2011 Nov;23(11):961–973. doi: 10.1111/j.1365-2826.2011.02180.x

Figure 8.

Figure 8

Intra-ventral tegmental area (VTA) infusions of the neurosteroidogenesis enhancer, FGIN 1–27, significantly enhanced lordosis quotients among ovariectomised, hormone-primed, female rats (n=3–10/grp) and infusions of anti-sense oligonucleotides to the VTA blocked this effect. * indicates significant main effect for FGIN 1–27 to enhance lordosis quotients compared to vehicle, p < 0.05. ** indicates significant main effect for anti-sense infusions to reduce lordosis quotients compared to mis-sense or vehicle-infusions, p < 0.05.